DE2318767C3 - Triamcinolon-Derivat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel - Google Patents

Triamcinolon-Derivat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel

Info

Publication number
DE2318767C3
DE2318767C3 DE2318767A DE2318767A DE2318767C3 DE 2318767 C3 DE2318767 C3 DE 2318767C3 DE 2318767 A DE2318767 A DE 2318767A DE 2318767 A DE2318767 A DE 2318767A DE 2318767 C3 DE2318767 C3 DE 2318767C3
Authority
DE
Germany
Prior art keywords
triamcinolone
preparation
product containing
medicinal product
ecm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2318767A
Other languages
German (de)
English (en)
Other versions
DE2318767B2 (de
DE2318767A1 (de
Inventor
Enrico Rom Diamanti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of DE2318767A1 publication Critical patent/DE2318767A1/de
Publication of DE2318767B2 publication Critical patent/DE2318767B2/de
Application granted granted Critical
Publication of DE2318767C3 publication Critical patent/DE2318767C3/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2318767A 1972-04-28 1973-04-13 Triamcinolon-Derivat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel Expired DE2318767C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT4994672A IT1057859B (it) 1972-04-28 1972-04-28 Perivato del triamoinolone

Publications (3)

Publication Number Publication Date
DE2318767A1 DE2318767A1 (de) 1973-11-08
DE2318767B2 DE2318767B2 (de) 1979-11-08
DE2318767C3 true DE2318767C3 (de) 1980-07-17

Family

ID=11271915

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2318767A Expired DE2318767C3 (de) 1972-04-28 1973-04-13 Triamcinolon-Derivat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel

Country Status (18)

Country Link
US (1) US3886145A (enExample)
JP (1) JPS5130073B2 (enExample)
AT (1) AT323910B (enExample)
AU (1) AU5490473A (enExample)
BE (1) BE798957A (enExample)
CA (1) CA986921A (enExample)
CH (1) CH571027A5 (enExample)
DE (1) DE2318767C3 (enExample)
DK (1) DK130994B (enExample)
ES (1) ES414163A1 (enExample)
FR (1) FR2183093B1 (enExample)
GB (1) GB1379867A (enExample)
IN (1) IN148707B (enExample)
IT (1) IT1057859B (enExample)
KE (1) KE2821A (enExample)
NL (1) NL178422C (enExample)
NO (1) NO138568C (enExample)
SE (1) SE395276B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY37269A (es) 2016-06-02 2018-01-02 Abbvie Inc Agonista del receptor de glucocorticoides e inmunoconjugados del mismo
MY199937A (en) 2016-11-08 2023-11-29 Regeneron Pharma Steroids and protein-conjugates thereof
CN110944718A (zh) 2017-05-18 2020-03-31 里珍纳龙药品有限公司 环糊精蛋白质药物偶联物
CA3080857A1 (en) 2017-11-07 2019-05-16 Regeneron Pharmaceuticals, Inc. Hydrophilic linkers for antibody drug conjugates
BR112020010694A2 (pt) 2017-12-01 2020-11-10 Abbvie Inc. agonista de receptor de glicocorticoides e imunoconjugados do mesmo
AU2019205542B2 (en) 2018-01-08 2025-10-23 Regeneron Pharmaceuticals, Inc. Steroids and antibody-conjugates thereof
CN112533951A (zh) 2018-05-09 2021-03-19 里珍纳龙药品有限公司 抗msr1抗体及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990401A (en) * 1958-06-18 1961-06-27 American Cyanamid Co 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids
US3197469A (en) * 1958-08-06 1965-07-27 Pharmaceutical Res Products In 16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
US3035050A (en) * 1960-08-19 1962-05-15 Olin Mathieson 1-dehydrogenation of 11beta-hydroxy steroids by 2, 3-dibromo-5, 6-dicyanoquinone
US3488727A (en) * 1968-03-15 1970-01-06 Squibb & Sons Inc 7alpha-hydroxy-16,17-acetals and ketals of the pregnene series

Also Published As

Publication number Publication date
DE2318767B2 (de) 1979-11-08
AT323910B (de) 1975-08-11
KE2821A (en) 1978-03-31
JPS4947369A (enExample) 1974-05-08
DK130994C (enExample) 1975-10-13
AU5490473A (en) 1974-10-31
ES414163A1 (es) 1976-02-16
US3886145A (en) 1975-05-27
DK130994B (da) 1975-05-12
CA986921A (en) 1976-04-06
SE395276B (sv) 1977-08-08
IT1057859B (it) 1982-03-30
NL178422C (nl) 1986-03-17
FR2183093A1 (enExample) 1973-12-14
NO138568C (no) 1978-10-04
DE2318767A1 (de) 1973-11-08
IN148707B (enExample) 1981-05-16
NL178422B (nl) 1985-10-16
GB1379867A (en) 1975-01-08
NO138568B (no) 1978-06-19
CH571027A5 (enExample) 1975-12-31
FR2183093B1 (enExample) 1976-12-03
JPS5130073B2 (enExample) 1976-08-30
NL7305897A (enExample) 1973-10-30
BE798957A (fr) 1973-08-16

Similar Documents

Publication Publication Date Title
DE2318767C3 (de) Triamcinolon-Derivat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
CH618686A5 (enExample)
DE2512915C2 (enExample)
DE1618065B2 (de) 21-oxo-23-desoxo-cardenolide, verfahren zu deren herstellung und daraus hergestellte arzneimittel
DE2426779A1 (de) 1.3-oxygenierte 8 alpha-oestratriene
CH640247A5 (de) Steroid-spiro-oxazolidone und verfahren zu ihrer herstellung.
DE1468424A1 (de) Verfahren zur Herstellung von Steroid-Verbindungen
DE2004301A1 (de) Phenylserinderivate
DE1807585C3 (de) 14,15beta-Epoxycardenolide, Verfahren zu deren Herstellung und diese enthaltende Mittel
CH526526A (de) Verfahren zur Herstellung eines neuen 6a-Methyl-19-nor-progesterons
AT209007B (de) Verfahren zur Herstellung von 9 α-Halogen-4-pregnen-16 α, 17 α,21-triol-3, 11, 20-trionen und ihren Estern
DE1568219C3 (de) Derivate des Acovenosids A und Verfahren zu ihrer Herstellung
DE883435C (de) Verfahren zur Herstellung von Dioxyacetonverbindungen
DE1668857C (de) 6 alpha, 9 alpha Difluorprednisolon 17 valerat 21 acetat
DE1643652C (de) 3, 4 Diather des Helveticosids und Verfahren zu deren Herstellung
AT206590B (de) Verfahren zur Herstellung von neuen am Indolstickstoff substituierten Derivaten der Lysergsäure-Reihe
DE1807980C3 (de) Verfahren zur Herstellung neuer Halogenpregnadiene
DE1900898C3 (enExample)
DE1966921C3 (de) 17 alpha-propadienylsubstituierte 3-Ketosteroide und Verfahren zu deren Herstellung
DE1418320C (de) Verfahren zur Herstellung von 16 alpha-Methyl- 1,4-pregnadien-17 alpha, 21-diol-3,11,20-trion und von entsprechenden 21niedermolekularen Alkansäureestern desselben
DE1939164A1 (de) 14beta-Hydroxy-15alpha-acyloxy-cardenolide
DE2017533C3 (de) Neue Carbonatester von 6alpha, 9alpha-Difluor-11beta, 16alpha, 17alpha, 21 -tetrahydroxy-pregna-1,4-dien-3,20dion-16alpha-17alpha-acetonid, Verfahren zu deren Herstellung sowie diese enthaltendes Mittel
DE2006635C (de) löalpha, 17alpha (propen 2 yhden dioxy) 9 fluor 1 lbeta, 21 dihydroxy Delta hoch 1,4 pregnadiene bzw deren 21 Ester, Verfahren zu ihrer Herstellung und diese als alleinigen Wirkstoff ent haltende pharmazeutische Mittel
DE1199262C2 (de) Verfahren zur Herstellung von 5alpha-Brom-6beta-hydroxysteroiden
EP0684231A1 (de) Pharmazeutisches Präparat zur Modulierung der Immunreaktion und neue Indol- und Chinolinderivate

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8328 Change in the person/name/address of the agent

Free format text: SCHWABE, H., DIPL.-ING. SANDMAIR, K., DIPL.-CHEM. DR.JUR. DR.RER.NAT. MARX, L., DIPL.-PHYS. DR.RER.NAT., PAT.-ANW., 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee